4/A//SEC Filing
Longpre Lara 4/A
Accession 0001209191-21-018772
CIK 0001759425other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 7:48 PM ET
Size
5.7 KB
Accession
0001209191-21-018772
Insider Transaction Report
Form 4/AAmended
Longpre Lara
Chief Development Officer
Transactions
- Award
Stock Option (right to buy)
2021-01-07+65,000→ 65,000 totalExercise: $19.19Exp: 2031-01-06→ Common Stock (65,000 underlying)
Footnotes (2)
- [F1]This Form 4 is being amended to correct the transaction date.
- [F2]1/4th of the shares vest one year after January 7, 2021 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.
Documents
Issuer
Mirum Pharmaceuticals, Inc.
CIK 0001759425
Entity typeother
Related Parties
1- filerCIK 0001780347
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 7:48 PM ET
- Size
- 5.7 KB